Coeptis Therapeutics will merge with Z Squared, a company focused on Dogecoin mining, and plans to rename itself Z Squared, officially transitioning from a biopharmaceutical company to a digital asset mining enterprise. The merger will include the acquisition of 9,000 Dogecoin mining machines and the divestment of the original biopharmaceutical department. Following this news, Coeptis' stock price plummeted by nearly 40%, with a current market value of approximately $32 million. The new company will be led by Z Squared's current CEO David Halabu and COO Michelle Burke, with the goal of creating the largest Dogecoin mining public company in the United States.